Company Filing History:
Years Active: 1984
Title: Inventor Highlight: Hidefumi Takiuchi
Introduction
Hidefumi Takiuchi, an innovative inventor based in Kamakura, Japan, has made significant strides in the biomedical field. With a focus on creating advancements in medical materials, Takiuchi has contributed to the development of technology that enhances the safety and effectiveness of biomedical applications.
Latest Patents
Takiuchi holds a notable patent for an antithrombogenic biomedical material. This invention comprises a copolymer that includes not less than 5% by weight of one or more polymerizable monomers featuring a polyethylene oxide unit, along with a degree of polymerization not less than 5 and a polymerizable carbon-carbon double bond. Additionally, it can contain not more than 95% by weight of one or more monomers copolymerizable with the aforementioned monomer. This invention addresses the critical need for materials that prevent thrombosis in biomedical devices.
Career Highlights
Hidefumi Takiuchi is associated with Toray Industries, Inc., a leading company in advanced materials and technology. His work has contributed to the ongoing research and development efforts within the company, particularly in the biomedical sector. Takiuchi's patented work exemplifies his dedication to improving healthcare outcomes through innovative material science.
Collaborations
Throughout his career, Takiuchi has collaborated with esteemed colleagues such as Shoji Nagaoka and Yuichi Mori. These partnerships highlight the teamwork involved in advancing complex technological innovations and fostering an environment of shared knowledge in research and development.
Conclusion
Hidefumi Takiuchi's contributions to the field of biomedical materials, exemplified by his patented antithrombogenic biomedical material, underline the importance of innovation. His work not only represents a step forward in medical technology but also reflects the collaborative spirit within Toray Industries, Inc. As advancements continue in this field, Takiuchi’s efforts pave the way for enhanced biomedical applications and improved patient outcomes.